Clinical Trial

Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-11-03; most recent amendment 2026-06-02.
Trial Details
NCT Number NCT05120518
Lead Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Conditions Pediatric Cancer
Enrollment 150 participants
Start Date 2019-08-14
Primary Completion 2029-08-14 (estimated)
Study Completion 2029-08-14 (estimated)
Updated on ClinicalTrials.gov 2026-06-03